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Using an Instrumental Variable to Test for Unmeasured Confounding
Abstract
An important concern in an observational study is whether or not there is unmeasured confounding, that is,
unmeasured ways in which the treatment and control groups differ before treatment, which affect the
outcome. We develop a test of whether there is unmeasured confounding when an instrumental variable (IV)
is available. An IV is a variable that is independent of the unmeasured confounding and encourages a subject
to take one treatment level versus another, while having no effect on the outcome beyond its encouragement
of a certain treatment level. We show what types of unmeasured confounding can be tested for with an IV and
develop a test for this type of unmeasured confounding that has correct type I error rate. We show that the
widely used Durbin–Wu–Hausman test can have inflated type I error rates when there is treatment effect
heterogeneity. Additionally, we show that our test provides more insight into the nature of the unmeasured
confounding than the Durbin–Wu–Hausman test. We apply our test to an observational study of the effect of
a premature infant being delivered in a high-level neonatal intensive care unit (one with mechanical assisted
ventilation and high volume) versus a lower level unit, using the excess travel time a mother lives from the
nearest high-level unit to the nearest lower-level unit as an IV.
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Abstract: An important concern in an observational study is whether or not there is
unmeasured confounding, i.e., unmeasured ways in which the treatment and control groups
differ before treatment that affect the outcome. We develop a test of whether there is
unmeasured confounding when an instrumental variable (IV) is available. An IV is a variable
that is independent of the unmeasured confounding and encourages a subject to take one
treatment level vs. another, while having no effect on the outcome beyond its encouragement
of a certain treatment level. We show what types of unmeasured confounding can be tested
with an IV and develop a test for this type of unmeasured confounding that has correct
type I error rate. We show that the widely used Durbin-Wu-Hausman (DWH) test can have
inflated type I error rates when there is treatment effect heterogeneity. Additionally, we show
that our test provides more insight into the nature of the unmeasured confounding than the
DWH test. We apply our test to an observational study of the effect of a premature infant
being delivered in a high-level neonatal intensive care unit (one with mechanical assisted
ventilation and high volume) vs. a lower level unit, using the differential distance a mother
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lives from the nearest high-level unit to the nearest lower-level unit as an IV.
1 Introduction
An observational study is a comparison of treatment groups in which “the objective is to
elucidate cause-and-effect relationships [... in which it] is not feasible to use controlled
experimentation in the sense of being [able]... to assign subjects at random to different
procedures” (Cochran, 1965). A central concern in an observational study is confounding,
meaning that the treatment groups may differ before treatment in ways that affect the
outcome. If the ways in which the treatment groups differ are measured, these differences can
be adjusted for, e.g., by matching, stratification or regression (Rosenbaum, 2001). However,
there is often concern that there unmeasured ways in which the treatment groups differ that
affect the outcome, meaning that there is unmeasured confounding. Even when there is
unmeasured confounding, it is possible to obtain a consistent estimate of the causal effect
of treatment for a certain subpopulation (the compliers) if an instrumental variable (IV)
can be found. An IV is a variable that is independent of the unmeasured confounding and
encourages, but does not force a subject to take one treatment level vs. another, while
having no effect on the outcome beyond its encouragement of a certain treatment level. For
discussions of IVs, see Angrist, Imbens and Rubin (1996), Abadie (2002), Hernán and Robins
(2006), Tan (2006), Brookhart and Schneeweiss (2007), Cheng, Qin and Zhang (2009) and
Tan (2010). In this paper, we develop a method for using an IV to test whether there is
unmeasured confounding. Detecting whether there is unmeasured confounding is valuable in
many studies because if unmeasured confounding is found in a given study, it suggests that
for studying related questions, researchers should either try to measure more confounders or
seek to find IVs.
The existing and widely used test for whether there is unmeasured confounding using an
IV is the Durbin-Wu-Hausman endogeneity test, hereafter called the DWH test, indepen-
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dently proposed by Durbin (1954), Wu (1973) and Hausman (1978). The DWH test compares
an estimate of the average treatment effect under the assumption that there is no unmea-
sured confounding to an estimate of the average treatment effect using an IV that allows for
unmeasured confounding. The IV estimate of the average treatment effect is assumed to be
consistent so that a significant difference between it and the estimate that assumes no unmea-
sured confounding is taken as evidence of unmeasured confounding. The two estimates of the
average treatment effect in the DWH test assume that the treatment effect is homogeneous,
meaning that it is not associated with measured or unmeasured confounders; see Wooldridge
(2003), Hernán and Robins (2006), Basu et al. (2007), Brookhart and Schneeweiss (2007) and
Tan (2010) for discussion of homogeneity assumptions. Brookhart, Rassen and Schneeweiss
(2010) noted that if the DWH test rejects, one cannot be sure whether it is because of
unmeasured confounding or treatment effect heterogeneity.
In this paper, we discuss what types of unmeasured confounding can be tested for and
provide a test with correct type I error rate for the testable types of unmeasured confounding.
In addition to having the advantage over the DWH test of having correct type I error
rate when there is treatment effect heterogeneity, our testing approach also provides more
insight into the nature of the unmeasured confounding by providing separate tests for two
different types of unmeasured confounding. In the DWH test, these two types of unmeasured
confounding are lumped together.
The motivating application for our work is an observational study of neonatal care that
seeks to estimate the effect on mortality of a premature infant being delivered in a high-level
neonatal intensive care unit (NICU) vs. a lower-level NICU. A high-level NICU is defined
as NICU that has the capacity for sustained mechanical assisted ventilation and delivers at
least 50 premature infants per year. Estimating the effect of being delivered at a high-level
NICU is important for determining the value of a policy of regionalization of perinatal care
that aims for premature infants to be mostly delivered in high-level NICUs. (Lorch, Myers
and Carr, 2010). Regionalization of perinatal care was developed in the 1970s along with
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the expansion of neonatal technologies, but by the 1990s, regionalization began to weaken in
many areas of the United States (Howell et al., 2002). The difficulty in studying the causal
effect of a premature infant being delivered in a high-level vs. a lower-level NICU is that the
infants who are at most risk of death are most likely to be delivered at a high level NICU. In
our data from Pennsylvania (described in Section 6), the unadjusted death rate in high-level
NICUs is higher than in low-level NICUs, 2.3% vs. 1.2%. Our data contains a number of
potential confounders, including birth weight, gestational age, month prenatal care started,
mother’s comorbid conditions, mother’s socioeconomic status and mother’s insurance. After
adjustment for these measured confounders by propensity score matching, the death rate
is 0.5% lower in high-level NICUs with the difference being not significant at the .05 level
(Lorch et al., 2011). However, we are concerned about unmeasured potential confounders,
such as the severity of a mother’s comorbid condition or an infant’s antenatal condition, lab
results, fetal heart tracing results, the compliance of the mother to medical treatment and
the physician’s history with that mother. These variables are known to the physicians who
assess a mother’s probability of delivering a high-risk infant. Based on this probability, the
physicians then play a role in deciding where the mother should live. To attempt to deal
with the problem of potential unmeasured confounding, we have collected data on a proposed
IV, the excess travel time that a mother lives from the nearest high-level NICU compared
to the nearest lower-level NICU; specifically, the IV is whether or not the mother’s excess
travel time is less than or equal to 10 minutes. Excess travel time to a hospital delivering
specialty care has been used as an IV in other medical settings, such as studies of the effect
of cardiac catheterization on survival in patients who suffered an acute myocardial infarction
(McClellan et al., 1994) In obstetric care, prior work suggests that women tend to deliver at
the closest hospital with obstetric care so that we expect that excess travel time will have a
strong effect on where the infant is delivered (Phibbs, 1993). Our goal in this paper is to use
the putative IV excess travel time to test whether there is unmeasured confounding in the
study of the effect of high-level vs. lower-level NICUs. If unmeasured confounding is found,
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it suggests that previous studies of the effect of high-level vs. lower-level NICUs provide
biased estimates and that future studies of this and related medical questions should seek
to measure more confounders and/or find and measure IVs.
The rest of the paper is organized as follows. In Section 2, we set up the causal framework
and introduce notation and assumptions. In Section 3, we discuss what type of unmeasured
confounding can be tested for when there are heterogeneous treatment effects. In Section
4, we discuss the DWH test and how it performs when there are heterogeneous treatment
effects. In Section 5, we develop our method for testing unmeasured confounding. In Section
6, we apply our test to the study of the effect of high-level vs. lower-level NICUs. Finally,
we provide conclusions and discussion in Section 7.
2 The Framework
2.1 Notation
The IV Z and the treatment A are assumed to each be binary, where level 0 of the treatment
is considered the “control” (lower-level NICU in our application) and level 1 is considered to
be the “treatment” (high-level NICU in our application). We let Z denote the N -dimensional
vector of IV values for all N subjects, with individual elements Zi = z ∈ {0, 1} for subject i;
level 1 of the IV is assumed to encourage receiving the treatment compared to level 0. LetAz
be the N -dimensional vector of potential treatment under IV assignment z, with individual
element Azi = a ∈ {0, 1} according to whether subject i would take the control or treatment
under z. We let Yz,a be the vector of potential responses that would be observed under IV
levels z and treatment levels a, with individual element Y r,ai for subject i. {Y
r,a
i } and {Ari}
are “potential” responses and treatments in the sense that we can observe only one value in
each set. We let Yi and Ai be the corresponding observed outcome and treatment variables
for subject i. We let Xi denote the measured confounders for subject i. We assume that Xi
includes an intercept.
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2.2 Assumptions
We make the same assumptions as Angrist et al. (1996) within strata of the measured
confounders X.
Assumption 1: Stable unit treatment value assumption (SUTVA) (Rubin, 1986): (a) If z = z
′
, then
Azi = A
z
′
i . (b) If z = z
′
and a = a
′
, then Y z,ai = Y
z
′
,a
′
i . This assumption allows us to
write Y z,ai and A
z
i as Y
z,a
i and A
z
i , respectively, for subject i.
Assumption 2: IV is independent of unmeasured confounding: Conditional on X, the IV Z is indepen-
dent of the vector of potential responses and treatments (Y 0,0, Y 0,1, Y 1,0, Y 1,1, A0, A1) for
a randomly chosen subject.
Assumption 3: Exclusion restriction: For subject i, Y z,ai = Y
z
′
,a
i for all z, z
′
and a, i.e., the IV level
affects outcomes only through its effect on treatment level. This assumption allows us to
define Y ai ≡ Y
0,a
i = Y
1,a
i for a = 0, 1.
Assumption 4: Nonzero average causal effect of Z on A: E(A1 − A0|X) ̸= 0.
Assumption 5: Monotonicity: P (A1 ≥ A0) = 1. This assumption says that there is no one who would
always do the opposite of what the IV encourages, i.e., no one who would not take the
treatment if encouraged to do so by the IV level but would take the treatment if not
encouraged by the IV level.
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Table 1: The relation of observed groups and latent compliance classes under the monotonic-
ity assumption
Zi Ai Ci
1 1 co(Complier) or at (Always-taker)
1 0 nt (Never-taker)
0 0 nt (Never-taker) or co (Complier)
0 1 at (Always-taker)
2.3 Compliance Class
Based on a subject’s joint values of potential treatment (A0i , A
1
i ), a subject can be classified
into one of four latent compliance classes (Angrist et al., 1996):
Ci =

nt (never-taker) if (A0i , A
1
i ) = (0, 0)
co (complier) if (A0i , A
1
i ) = (0, 1)
at (always-taker) if (A0i , A
1
i ) = (1, 1)
de (defier) if (A0i , A
1
i ) = (1, 0)
Under the monotonicity assumption, there are no defiers. We can observe only one
of A0i and A
1
i , so a subject’s compliance class is not observed directly but it can be par-
tially identified based on IV level and observed treatment as shown in Table 1. Based
on Table 1, the following quantities are identified based on the observable data: P (C =
at) = P (A = 1|Z = 0), P (C = nt) = P (A = 0|Z = 1), P (C = co) = 1 − P (A =
1|Z = 0) − P (A = 0|Z = 1), E(Y 1|C = at) = E(Y |Z = 0, A = 1), E(Y 0|C = nt) =
E(Y |Z = 1, A = 0), E(Y 1|C = co) = E(Y |Z=1,A=1)−[P (C=at)/{P (C=at)+P (C=co)}]E(Y |Z=0,A=1)
P (c=co)/{P (C=at)+P (C=co)}
and E(Y 0|C = co) = E(Y |Z=0,A=0)−[P (C=nt)/{P (C=nt)+P (C=co)}]E(Y |Z=1,A=0)
P (c=co)/{P (C=nt)+P (C=co)} . The quantities
E(Y 1|C = nt) and E(Y 0|C = at) are not identified.
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3 Type of Unmeasured Confounding that Can Be Tested
For Using an IV
The average treatment effect is E(Y 1 − Y 0). Rosenbaum and Rubin (1983) and Imbens
(2004) discuss how the average treatment effect can be consistently estimated by propensity
score methods, matching methods regression methods under the following two assumptions:
0 < P (A = 1|X) < 1 (1)
(Y 1, Y 0) ⊥ A | X. (2)
Assumption (1) says that the support of the covariate distributions of the treated and control
units is the same; this is called the overlap assumption. Assumption (2) is called the un-
confoundedness assumption and holds if there are no unmeasured confounders of treatment
assigment (i.e., no unmeasured variables that are associated with both treatment assignment
and outcome). When the overlap assumption (1) does not hold, but the unconfoundedness
assumption (2) holds, then the average treatment effect on the common support of the co-
variate distributions of the treated and controls subjects can be consistently estimated. For
consistent estimation of the average treatment effect, the following conditions implied by (2)
are sufficient (Heckman, Ichimura and Todd, 1998; Imbens, 2007):
E(Y 1|A = 1,X) = E(Y 1|A = 0,X), (3)
E(Y 0|A = 1,X) = E(Y 0|A = 0,X). (4)
We will show that having a valid IV Z allows us to test certain aspects of (3)-(4), but not
other aspects.
We can decompose the two expected values in (3) into parts contributed by the compliance
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classes:
E(Y 1|A = 1) = P (C = at|X)
P (C = at|X) + P (Z = 1|X)P (C = co|X)
E(Y 1|C = at,X) +
P (Z = 1|X)P (C = co|X)
P (C = at|X) + P (Z = 1|X)P (C = co|X)
E(Y 1|C = co,X), (5)
E(Y 1|A = 0) = P (C = nt|X)
P (C = nt|X) + P (Z = 0|X)P (C = co|X)
E(Y 1|C = nt,X) +
P (Z = 0|X)P (C = co|X)
P (C = nt|X) + P (Z = 0|X)P (C = co|X)
E(Y 1|C = co,X). (6)
Although there are a variety of ways for (5) to equal (6), the way that seems most easily
discussed with collaborators as to whether it is plausible and that is most easily generalized
to other related studies is for the expected potential outcome under treatment given the
measured confounders X to be the same for all three compliance classes:
E(Y 1|C = at,X) = E(Y 1|C = co,X) = E(Y 1|C = nt,X). (7)
As discussed in Section 2.3, the IV Z identifies E(Y 1|C = at,X) and E(Y 1|C = co,X) but
not E(Y 1|C = nt,X). Thus, we can test the following aspect of (7):
E(Y 1|C = at,X) = E(Y 1|C = co,X) for all X. (8)
Similarly, a way for (4) to hold is for
E(Y 0|C = at,X) = E(Y 0|C = co,X) = E(Y 0|C = nt,X), (9)
and the IV Z enables us to test the following aspect of (9):
E(Y 0|C = co,X) = E(Y 0|C = nt,X) for all X. (10)
To summarize, a valid IV Z enables us to test the aspects (8) and (10) of (7) and (9)
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respectively, where (7) and (9) holding together ensure that the no unmeasured confounders
assumption (2) holds.
We now discuss what information is learned from the test of (8) and (10). Suppose one
of tests rejects, e.g., suppose there is evidence that E(Y 1|C = at,X) > E(Y 1|C = co,X).
Then, in the NICU study (where Y is mortality), conditional on measured confounders X,
among the always takers and compliers, infants who are more likely to be delivered at a high
level NICU (always takers) are in worse underlying condition than infants who are less likely
to be delivered at a high level NICU (compliers). This indicates that there are unmeasured
confounders that are associated with both (i) selection of whether to go to a high level NICU
and (ii) mortality. It is still possible that the unconfoundedness assumption (2) assumption
holds through some cancellation of the effects of these unmeasured confounders with other
unmeasured confounders, but it seems unlikely. Now suppose that the (8) and (10) are true.
This does not necessarily imply that unconfoundedness (2) holds, but it does imply that
(2) holds under the following additional assumption that the average treatment effect is the
same for the different compliance classes conditional on the measured confounders X:
E(Y 1 − Y 0|C = at,X) = E(Y 1 − Y 0|C = co,X) = E(Y 1 − Y 0|C = nt,X).
4 DWH Test
The DWH test statistic TDWH is the following. Let β̂OLS denote the ordinary least squares
(OLS) estimates of the regression of Y on A and X and let β̂2SLS denote the two stage least
squares (2SLS) estimates of the effects of A and X on Y , namely β̂2SLS is computed by first
regressing A on Z,X by least squares and finding the predicted value Â and then regressing Y
on Â,X by least squares. The DWH test statistic is an assessment of the difference between
the OLS and 2SLS estimates,
TDWH = (β̂OLS − β̂2SLS)T (Cov{β̂2SLS} − Cov{β̂OLS})+(β̂OLS − β̂2SLS), (11)
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where (Cov{β̂2SLS}−Cov{β̂OLS})+ is the Moore-Penrose pseudo-inverse of (Cov{β̂2SLS}−
Cov{β̂OLS})+. The covariances in (11) are the covariances that come for the normal linear
regression model or normal simultaneous equations model that make the homoskedasticity
assumption that V ar(Y 0|X) is equal to V ar(Y 1|X) and the same for all X, Under the null
hypothesis that the aspects (8) and (10) of unconfoundendess hold in addition to the average
treatment effect for compliers being homogeneous inX (i.e., E(Y 1−Y 0|C = co,X is the same
for all X), E(Y 0|X) being linear in X and a homoskedasticity assumption that V ar(Y 0|X)
is equal to V ar(Y 1|X) and the same for all X, the null distribution of TDWH is chi-squared
with 1 degree of freedom (Durbin, 1954; Wu, 1973; Hausman, 1978).
We now consider the properties of the DWH test when the aspects (8) and (10) hold,
but average treatment effects are heterogeneous in X. The DWH test statistic TDWH is the
difference between the ordinary least squares estimate of the treatment effect from a linear
regression of Y on A and X (namely, the coefficient on A in this linear regression) and the
two stage least squares estimate of the treatment effect that uses the IV Z, namely the
coefficient on Ê(A|X, Z) from a regression of Y on Ê(A|X, Z) and X, where Ê(A|X, Z) is
obtained from a linear regression of A on X and Z. Let β̂OLS and β̂TSLS denote the ordinary
least squares and two stage least squares treatment effect estimates respectively. Under the
null hypothesis that E(Y (0)|X) is linear in X and E(Y (1) − Y (0)|C,X) is the same for all
C,X, the asymptotic null distribution of TDWH is a mean zero normal random variable with
variance V ar(β̂TSLS)− V ar(β̂OLS), where the variances are under the null hypothesis.
Suppose (8) and (10) hold. We will show that the DWH test may still reject with
probability converging to 1 when there are heterogeneous treatment effects. This is because
β̂OLS and β̂TSLS are converging to different weighted averages of treatment effects. Let
βX = E(Y
1 − Y 0|C = co,X). Suppose E(Yi|Xi, Ai = 0) is linear in Xi and (8) and
(8) and (10) hold. Then E(Y |A = 1,X) − E(Y |A = 0,X) = βX. Then, we have the
following expression for the probability limit of the OLS estimator where E∗(A|B is the
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linear projection of A onto B, namely E∗(A|B) = αTB, α = argminα∗ E(A− (α∗)TB,
plimβ̂OLS =
E[(Ai − E∗(Ai|Xi))(Yi − E∗(Yi|Xi))]
E[(Ai − E∗(Ai|Xi))2
(12)
=
E[(Ai − E∗(Ai|Xi))Yi]
E[(Ai − E∗(Ai|Xi))2
(13)
=
E[(Ai − E∗(Ai|Xi))E(Yi|Xi, Ai)]
E[(Ai − E∗(Ai|Xi))2
(14)
=
E[(Ai − E∗(Ai|Xi))(E(Yi|Xi, Ai = 0) + βXAi]
E[(Ai − E∗(Ai|Xi))]2
(15)
=
E[(Ai − E∗(Ai|Xi))2βX]
E[(Ai − E∗(Ai|Xi))2]
(16)
Thus, the OLS estimator converges to a weighted average of treatment effects at different
values of X, where the values of X that get the most weight are those where E[(Ai −
E∗(Ai|Xi))2] is largest. If E(Ai|Xi) is linear inX, then E[(Ai−E∗(Ai|Xi))2] is the conditional
variance of A given X. We use the fact that any linear function of Xi is independent of Ai−
E∗(Ai|Xi) to derive (13) and (16) and we iterate expectations over Xi and Ai to derive (14).
If E(Yi|Xi, Ai = 0) is not linear in Xi, then plimβ̂OLS equals (16) plus E[(Ai−E
∗(Ai|Xi))E(Y 0|X)]
E[(Ai−E∗(Ai|Xi))2] .
Angrist and Krueger (1999) derive similar expressions assuming E(Ai|Xi is linear in Xi.
Similarly,
plimβ̂TSLS = E[V ar(E(Ai|Xi, Zi)|Xi)βX]/E[V ar(E(Ai|Xi, Zi)|Xi)]
= E[P (C = co|Xi)2P (Zi = 1|Xi)(1− P (Zi = 1|Xi))βX]
E[P (C = co|Xi)2P (Zi = 1|Xi)(1− P (Zi = 1|Xi))].
Thus, the TSLS estimator converges to a weighted average of treatment effects at different
values of X, where the values of X that tend to get the most weight are those for which the
proportion of compliers is highest. A value of X at which there are no compliers gets zero
weight.
We estimated the TSLS and OLS weights for the NICU data set. Table 4 shows the
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Table 2: Comparison of population, OLS and TSLS weights
Condition Population OLS TSLS
Proportion Weight Weight
Pregnancy induced hypertension .104 .098 .080
Gestational diabetes .052 .052 .045
Pre-term labor .447 .433 .338
weights for some key variables. Mothers with pregnancy-induced hypertension, gestational
diabetes and pre-term labor are less likely to be compliers and hence receive less weight in
the instrumental variable two stage least squares analysis.
5 Test Based on IV Propensity Score Subclassification
Estimate
One approach to testing (8)-(10) would be to fit a parametric model for the data as in
Hirano, Imbens, Rubin and Zhou (2000) and test (8)-(10) through the parameters of the
model. This test might involve a large number of degrees of freedom. To gain more power
for the particular contrasts of interest, our approach is to choose a covariate distribution
F (X) that we are interested in and test
EF (Y
1|C = at,X) = EF (Y 1|C = co,X) (17)
EF (Y
0|C = nt,X) = EF (Y 0|C = co,X) (18)
Three particular covariate distributions that could be of interest are (1) the distribution of
X over the whole study population; (2) the distribution of X over the compliers; (3) the
distribution of X over the compliers and never takers. (1) is of interest for comparing a
policy that provides the treatment to everybody to a policy that provides the treatment to
nobody; this contrast is not of particular interest for the NICU study because eliminating
all high-level NICUs is not a policy that is being considered. (2) is of interest for comparing
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a policy that provides the encouraging level of the IV to everybody versus a policy that
provides the encouraging level of the IV to nobody; this contrast is of interest for the NICU
study because it compares the policy of building enough high level NICUs so that everybody
lives close to one to a policy in which there are very few high level NICUs so that everybody
lives far from one. (3) is of interest for comparing a policy that provides the treatment
to everybody to a policy that provides the not encouraging level of the IV to everybody;
this contrast is of interest for the NICU study because it compares the policy of sending all
premature infants to high level NICUs to the policy of having few high level NICUs so that
most people live far from one.
To estimate the quantities in (17)-(18), we use the approach of subclassification on the
IV propensity score of Cheng (2011). This approach is an extension to the IV setting
of subclassification on the propensity score for estimating average treatment effects under
strongly ignorable treatment assignment (Rosenbaum and Rubin, 1984). The basic idea is
that we create subclasses in which the covariate distribution of X is approximately the same
between the Z = 1 and Z = 0 groups, then estimate the quantities in (17)-(18) within the
subclass using methods that assume the IV is independent of X within the subclass and then
weight the subclass estimates appropriately to obtain overall estimates of (8)-(18).
1. We construct subclasses over which the distribution of the covariates X in the Z = 1 and
Z = 0 groups are approximately equal. To construct these subclasses, we estimate the
IV propensity score, P (Z = 1|X) and then divide the subjects by their IV propensity
scores into five subclasses. This borrows Rosenbaum and Rubin (1984)’s approach for
estimating average treatment effects under strongly ignorable treatment assignment of
subclassifying on the propensity score for treatment assignment, P (A = 1|X). Rosen-
baum and Rubin, building on results in Cochran (1968), showed that subclassifying on
the propensity score removes approximately 90% of the initial bias in X. Since we are
interested in creating subclasses that have an equal distribution between the Z = 1 and
Z = 0 groups, we use the IV propensity score instead of the usual propensity score. To
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check balance of covariates X in the Z = 1 and Z = 0 groups has been achieved, the
diagnostics suggested by Rosenbaum and Rubin (1984) and Stuart (2010) can be used;
see our application in Section 6 for an illustration.
2. Within each subclass, the IV Z is approximately independent of X and by Assumption
2 for IVs, Z is independent of any unmeasured confounders. Consequently, within the
subclass, Z can be considered to be approximately randomly assigned. For randomly
assigned IVs, Cheng (2009) developed maximum likelihood estimates of the quantities
E(Y 1|C = at), E(Y 1|C = co), E(Y 0|C = nt), E(Y 0|C = co), P (C = at), P (C = co)
and P (C = at); see Baker (2010) and Cheng (2010) for further discussion.
3. For each subclass, estimate PF (X in subclass) and weight the subclass estimates by these
probabilities to form the overall estimates. For example, for F being the distribution of
X over the whole study population, we weight the subclasses by the number of subjects
in the subclass. For F being the distribution of X over the compliers, we weight the
subclasses by P̂ (C = co|subclass)× number of subjects in subclass.
4. We use the bootstrap to obtain confidence intervals for EF (Y
1|C = at,X)−EF (Y 1|C =
co,X) and EF (Y
0|C = nt,X) − EF (Y 0|C = co,X), and check if zero is in the confi-
dence intervals; if zero is not in either confidence interval, this indicates unmeasured
confounding of the type discussed in Section 3. The bootstrap is carried out treating the
distribution of the covariates X and Z as fixed, so that the subclasses and the number of
Z = 1 and Z = 0 within each subclass are the same as the actual data for each bootstrap
iteration, and we just resample the (Y,A)|Z = 1 and (Y,A)|Z = 0 within each subclass.
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6 Application to Study of High-Level NICUs vs. Lower-
Level NICUs
We obtained birth certificates from all deliveries occurring in Pennsylvania. Each state’s
department of health linked these birth certificates to death certificates using name and date
of birth, and then de-identified the records. We then matched over 98% of birth certificates to
maternal and newborn hospital records using prior methods (references from Scott) Over 80%
of the unmatched birth certificate records were missing hospital, suggesting a birth at home
or a birthing center. The unmatched records had similar gestational age and racial/ethnic
distributions to the matched records. The Institutional Review Boards of The Children’s
Hospital of Philadelphia and the department of health in Pennsylvania approved this study.
Infants included in this study had a gestational age between 23 and 37 weeks, and a birth
weight between 400 to 8000 grams. Birth records were excluded if the birth weight was more
than 5 standard deviations from the mean birth weight for the recorded gestational age in
the cohort. There are 192,078 infants in the final cohort. The primary outcome for this
study is neonatal death, defined as any death during the initial birth hospitalization.
Baiocchi, Small, Lorch and Rosenbaum (2010) discussed a matching approach to esti-
mating the complier average causal effect, E(Y 1−Y 0|C = co), for this study. Here our focus
is on using the IV of excess travel time to test for whether there is unmeasured confounding.
The IV is Z = 1 if a mother’s excess travel time to the nearest high level NICU compared
to the nearest hospital is 10 minutes or less, Z = 0 if her excess travel time is more than
10 minutes. Discussion of IV assumptions for application. Excess travel time is correlated
with whether a mother delivers at a high level NICU because a mother typically obtains
prenatal care from and would prefer to deliver at a close by facility (Phibbs et al., 1993).
Excess travel time is unlikely to have a direct effect on the outcome because presumably, a
nearby hospital with a high level NICU only affects the baby if the baby receives care at
that hospital. The third assumption, that excess travel time is independent of unmeasured
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confounders, is plausible after controlling for measured characteristics that predict where
people live (e.g., race and socioeconomic status).
The measured confounders X include birth weight and gestational age; maternal sociode-
mographic factors, such as race, age, education, and insurance status; sociodemographic
characteristics of the zip code the mother lives in; maternal comorbid conditions such as
gestational diabetes and hypertension; prenatal care and congenital anomalies. We fit a
logistic propensity score model P (Z|X = exp(λ
T
X)
1+exp(λTX)
. Following the approach of Crump,
Hotz, Imbens and Mitnik to dealing with limited overlap, we limited our study sample to
those infants with propensity scores between 0.1 and 0.9, leaving 165,868 infants. We then
divided the infants into five subclasses equally spaced along the range of propensity scores
[0.1, 0.9], namely [0.10, 0.26), [0.26, 0.42), [0.42, 0.58), [0.58, 0.74), [0.74, 0.90].
The standardized difference between the infants living near to a high level NICU (Z = 1)
and far from a high level NICU (Z = 0) before and after the subclassification are dis-
played in Table 3. The standardized difference of a covariate X before subclassification is
X̄near−X̄far√
s2X,near+s
2
X,far/2
(Rosenbaum and Rubin, 1985). This is the difference in means of the co-
variate between the near and far group divided by the standard deviation of the covariate,
where the standard deviation is calculated in a way that gives equal weight to the near and
far groups. The standardized difference of a covariate X after subclassification is
∑5
s=1(X̄near,s − X̄far,s)√
s2X,near + s
2
X,far/2
, (19)
where X̄near,s and X̄far,s are the means of the covariate X for the near and far infants in
subclass s respectively and ws is the proportion of infants in subclass s. The numerator in
(19) is the average difference in means of the covariate X between the near and far groups
within a subclass, weighted by the number of infants in the subclass. The denominator in (19)
is the standard deviation of the covariate calculated in the same way as for the standardized
difference before subclassification. The standardized differences before subclassification in
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Table 3 show that near infants had substantially lower birth weight, a later start to prenatal
care, were more likely to have non-white mothers, were less likely to have fee for service
insurance and more likely to have federal/state insurance and lived in neighborhoods with
more poverty. The standardized differences after subclassification are all less than or equal
to 0.05 (with most being 0.01 or less) indicating that the subclassification has succeeded
in balancing the covariance distribution between the near and far infants within subclasses.
Because of space limitations, Table 3 does not show the standardized differences for all
of the maternal comborbidities and complications during pregnancy and infant congenital
anomalies, but all of these covariates have standardized differences after subclassification of
0.05 or less.
The estimates and confidence intervals for the mean potential outcomes for the compli-
ance classes under the covariate distribution of the compliers are shown in Table 4. The fifth
line, E(Y 1|C = co)−E(Y 0|C = co), shows that we estimate that for compliers, attending a
high level NICU reduces the death rate by 0.8%, with a 95% confidence interval of a 0.6%
to 1.0% reduction. The sixth line, E(Y 1|C = at) − E(Y 1|C = co), displays the test of
unmeasured confounding (8). Always takers appear to have much higher death rates than
compliers who attend high level NICUs; the 95% confidence interval for the difference is 3.1%
to 3.6%. This is evidence that there is unmeasured confounding. Infants who live far away
from high level NICUs but are nevertheless delivered at high level NICUs are in substantially
worse health than infants who only deliver at a high level NICU when they live close to one
even after controlling for all of the covariates in Table 3. The seventh line, 10, displays the
test of unmeasured confounding (10). The death rates of never takers and compliers who
deliver at low level NICUs appear to be comparable, and there is not evidence of unmeasured
confounding in this dimension. Infants who would always deliver at a low level NICU no
matter whether they live near or far from a high level NICU appear to comparable in their
health to infants who would deliver at a high level NICU if they lived close to one but a low
level NICU if they lived far from a high level NICU.
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Table 3: Covariate balance before and after subclassification. The subclasses are the following ranges of
propensity scores: [0.10, 0.26), [0.26, 0.42), [0.42, 0.58), [0.58, 0.74), [0.74, 0.90]; subjects with propensity scores
less than 0.1 or greater than 0.9 are not considered. |St-dif| = absolute standardized difference. 1/0 means
1=yes, 0=no. Prenatal care month refers to month in which prenatal care began. Mother’s education scale is
a six point scale with high school graduate scored as 3 and college graduate scored as 5. For Zip Code/Census
data, fr = fraction of Zip Code. In addition to the results shown, 20 additional maternal complications during
pregnancy and ten congenital anomialies also have an absolute standardized difference of 0.05 or less.
Before Subclassification After Subclassification
Near Far |St-dif| Near Far |St-dif|
Mean Mean Mean Mean
Covariates Pregnancy and Birth
Birth Weight (grams) 2,552 2,629 0.11 2,613 2,614 0.00
Gestational Age (weeks) 35.02 35.27 0.09 35.20 35.21 0.00
Gestational Diabetes (1/0) 0.05 0.05 0.00 0.05 0.05 0.01
Preg. Induced Hypertension (1/0) 0.11 0.10 0.02 0.10 0.10 0.00
Pre-term labor (1/0) 0.45 0.44 0.03 0.44 0.45 0.00
Prenatal Care (month) 2.43 2.20 0.17 2.24 2.23 0.00
Prenatal Care Missing 0.13 0.07 0.20 0.09 0.09 0.02
Single Birth (1/0) 0.83 0.83 0.00 0.82 0.82 0.05
Parity 2.18 2.04 0.11 2.05 2.05 0.02
Mother
Mother’s Age 28.06 28.04 0.01 28.47 28.47 0.05
Mother’s Education (scale) 3.68 3.70 0.02 3.80 3.80 0.00
Mother’s Education Missing 0.03 0.01 0.14 0.02 0.02 0.00
White (1/0) 0.59 0.85 0.60 0.79 0.79 0.01
Black (1/0) 0.26 0.05 0.65 0.08 0.08 0.02
Asian (1/0) 0.02 0.01 0.08 0.01 0.01 0.00
Other Race (1/0) 0.04 0.02 0.14 0.03 0.03 0.01
Race Missing (1/0) 0.09 0.07 0.05 0.09 0.08 0.01
Mother’s Health Insurance
Fee For Service (1/0) 0.18 0.25 0.18 0.24 0.23 0.01
HMO (1/0) 0.37 0.35 0.05 0.39 0.39 0.04
Federal/State (1/0) 0.33 0.28 0.11 0.26 0.26 0.00
Other (1/0) 0.10 0.09 0.10 0.10 0.10 0.00
Uninsured (1/0) 0.01 0.02 0.04 0.01 0.01 0.00
Mother’s Neighborhood (Zip Code/Census)
Income ($1000) 40 42 0.11 44 44 0.01
Below Poverty (fr) 0.15 0.10 0.19 0.09 0.09 0.00
Home Value ($1000) 92 101 0.02 106 107 0.03
Has High School Degree (fr) 0.79 0.82 0.36 0.82 0.83 0.01
Has College Degree (fr) 0.22 0.20 0.15 0.22 0.22 0.01
Rent (fr) 0.33 0.25 0.65 0.27 0.27 0.01
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Table 4: Inferences for NICU Study Under Covariate Distribution of Compliers
Estimand Estimate 95% CI
E(Y 1|C = co) 0.002 (0.001, 0.005)
E(Y 0|C = co) 0.010 (0.009, 0.012)
E(Y 1|C = at) 0.036 (0.034, 0.037)
E(Y 0|C = nt) 0.013 (0.011, 0.014)
E(Y 1|C = co)− E(Y 0|C = co) -0.008 (-0.010, -0.006)
E(Y 1|C = at)− E(Y 1|C = co) 0.034 (0.031, 0.036)
E(Y 1|C = co)− E(Y 1|C = nt) -0.002 (-0.004, 0.001)
7 Conclusions and Discussion
We have developed a test of whether there is unmeasured confounding when an instrumental
variable (IV) is available. Our test has correct type I error rate unlike the Durbin-Wu-
Hausman (DWH) test, which can have inflated type I error rates when there is treatment
effect heterogeneity. An important additional advantage of our approach over the DWH test
is that it breaks up the test into the two parts (8)-(10), providing more information. For the
application, we found that always takers are at much higher risk of death than compliers
when both groups are delivered at high level NICUs but there is not a big difference between
the never takers and compliers when both groups are delivered at lower-level NICUs.
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